Research suggests that the increased use of antibiotics in the treatment of COVID-19 patients could be placing an additional burden on waste water treatment works, particularly those serving large or ...

Bacterial infections that don’t respond to treatment are a leading cause of death around the world. In 2019, antimicrobial resistance caused an estimated 1.27 million deaths, researchers report ...

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial At a minimum ...

There are several alternative cancer treatments to chemotherapy, including immunotherapy, photodynamic therapy, and laser therapy. Depending on the type and stage of cancer, doctors may recommend ...

In an interim analysis of this phase 3 trial, the addition of pembrolizumab to chemotherapy resulted in longer progression-free survival than chemotherapy alone among patients with advanced ...

FARMINGTON, Conn.--(BUSINESS WIRE)--DeBogy Molecular, Inc, a privately held biotech that specializes in antimicrobial surface modification, announced their Board of Directors has approved a new ...